Firocoxib

£28,500.00

Firocoxib is a highly selective COX-2 inhibitor non-steroidal anti-inflammatory drug (NSAID), recognized globally for its precision in managing postoperative pain and inflammation in equine and canine patients with a superior gastrointestinal safety profile compared to non-selective alternatives.

Competitive Advantage Spotlight
Its market distinction lies in its exceptional COX-2 selectivity, which delivers potent, targeted relief while minimizing the renal and gastrointestinal adverse events associated with traditional NSAIDs, thereby reducing the total cost of care and improving treatment compliance in high-value veterinary practices.

Description

1. Product Overview

Firocoxib is a selective non-steroidal anti-inflammatory drug (NSAID) designed for veterinary use, primarily targeting inflammation and pain management in animals. Its high selectivity for COX-2 enzymes ensures effective anti-inflammatory action while minimizing gastrointestinal side effects, making it a preferred choice for animal health professionals. Strategically, Firocoxib offers veterinarians and livestock operators a reliable, clinically proven solution for maintaining animal welfare and productivity. Its consistency and efficacy make it an essential product in veterinary pharmaceutical portfolios globally.


2. Key Specifications & Technical Characteristics

  • Chemical Composition: C<sub>20</sub>H<sub>16</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>S (Firocoxib active ingredient)
  • Purity Level: ≥ 99% (pharmaceutical/industrial grade)
  • Physical Characteristics: White to off-white crystalline powder; free-flowing; particle size typically 50–200 μm; density ~1.5 g/cm³
  • Packaging Options: 25 kg fiber drums with inner PE lining, custom bulk packaging available on request
  • Shelf Life: 36 months under recommended storage conditions (cool, dry, dark environment)

3. Core Industrial Applications

  • Primary Industries: Veterinary pharmaceuticals, animal health products, livestock production, companion animal care
  • Operational Use Cases:
    • Formulation of oral tablets, chewables, or injectable veterinary medications
    • Pain and inflammation management in dogs, horses, and livestock
  • Performance Advantages:
    • High COX-2 selectivity reduces gastrointestinal and renal risks compared to non-selective NSAIDs
    • Stable under formulation and storage conditions, ensuring consistent dosing and efficacy
    • Cost-effective solution due to high potency and low required dosage

4. Competitive Advantages

  • Quality Consistency: Batch-to-batch uniformity ensures reliable therapeutic outcomes
  • Supply Reliability: Secure global sourcing network supports continuous production and distribution
  • Logistics Capability: Compatible with bulk and containerized shipping; robust packaging for long-distance transport
  • Price Competitiveness: Optimized production costs allow attractive pricing for large-scale buyers
  • Sustainability: Manufactured following environmentally responsible processes
  • Technical Support: Comprehensive documentation including Certificates of Analysis (CoA), regulatory compliance data, and formulation guidance

5. Commercial & Supply Information

  • Minimum Order Quantity (MOQ): BULK 20 MT
  • Loading Capacity: Up to 20 MT per 20-ft container, depending on packaging configuration

Firocoxib is positioned as a strategic sourcing choice for veterinary pharmaceutical manufacturers and animal health product distributors seeking high-purity, reliable, and commercially advantageous anti-inflammatory agents.

Reviews

There are no reviews yet.

Be the first to review “Firocoxib”

Your email address will not be published. Required fields are marked *

Add to cart